Using this process, colorectal tumor cells have been shown to acquire immune receptors (e.g., CD45 and CD4) and functional immunoregulatory molecules (e.g., Tim3, CTLA-4 and PD-1) from T cells, thus enhancing tumor immunosuppression [49]. The gene discussed is CTLA4; the disease is neoplasm.